|
Merrill Lynch MITTS AMEX Biotech Index due 5/04/2009
Ticker Symbol: BMA* CUSIP: 59021J588 Exchange: AMEX
* NOTE: This security is no longer trading as of 5/04/2009
QUANTUMONLINE.COM SECURITY DESCRIPTION: Merrill Lynch & Co. Inc., AMEX Biotech Index Callable MITTS (Market Index Target-Term Securities), $10 principal amount, based on the AMEX Biotechnology Index (starting value 436.49), callable in September 2005 at the option of ML at $12.60 per unit, due 5/04/2009. The MITTS make no payments before maturity. At maturity the MITTS will pay a minimum of the $10 principal amount, plus an additional amount, which will not be less than zero, based on the increase, if any, in the value of the AMEX Biotechnology Index. The MITTS are senior unsecured debt securities issued by Merrill Lynch & Co. Inc. and will rank equally with all other unsecured and unsubordinated debt of Merrill Lynch. See the IPO prospectus for further information on the MITTS by clicking on the ‘Link to IPO Prospectus’ provided below.
|
Go to Parent Company's Record (BAC)
IPO - 5/2/2002 - 1.00 Million Units @ $10.00/unit.
Link to IPO Prospectus
Market Value $9.6 Million
Company's Online Information Links
|
HOME PAGE:
http://www.ml.com/
(This parent company URL is for reference only and does not have specific information on the security.)
|
Company's Online SEC EDGAR Filings |
Company's Email Address Links |
Address and Phone Numbers |
Address: 4 World Financial Center, North Tower, New York, NY 10080 |
Main Phone Number |
212-449-1000 |
Fax Number |
212-236-4384 |
Investor Relations
|
866-607-1234
|
Toll Free Phone Number |
800-637-7455 |
CEO - David H. Komansky |
CFO - Thomas H. Patrick |
Find a problem? Please use our Feedback Page or Email us.
Have you filled out our Guestbook? If not, please do.
|
|